N.Y. AG Spitzer Criticizes FDA "Silence" On Disclosing Rx Trial Data
This article was originally published in The Pink Sheet Daily
In a speech at the National Press Club, Eliot Spitzer discusses his lawsuit against GlaxoSmithKline that resulted in a settlement in which the company will publicly disclose clinical trial data. He says FDA "has not said a word" that would require other drug manufacturers to do the same.
You may also be interested in...
Forest Labs has agreed to post summaries of all Phase III and Phase IV trials on the Internet to resolve an investigation into the company by New York Attorney General Eliot Spitzer
The settlement includes a modest $2.5 mil. disgorgement fee. GSK is also required to advertise the clinical trial register in seven prominent peer reviewed journals.
New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.